Company Data
NervGen Pharma Corp
Ticker
NGENF
Current Price
$1.97 -1.5%
Market Cap
$138.3M
Price Target
Refer to Report
Volume
172.6K
52wk Range
$1.16 - $2.99
Overview
NervGen Pharma Corp is a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the treatment of spinal cord injury, multiple sclerosis, and Alzheimer’s disease. It operates in a single segment, which is the research and development of pharmaceutical drugs.